|Amylin Pharmaceuticals||California, San Diego, United States|
|Avoro Capital Advisors||New York, New York, United States|
|BHP||Australia, Melbourne, Victoria|
|Blueflame Capital||China, Qingdao, Shandong|
|Brandify||Anaheim, California, United States|
|Economic Development of the Longueuil Conurbation||Boucherville, Canada, Quebec|
|Franklin Square Group||District of Columbia, United States, Washington|
|Jayant Group||Bilaspur, Chhattisgarh, India|
|Manipal Hospitals||Bangalore, India, Karnataka|
|Presidio Partners||California, San Francisco, United States|
|Prestige Angel||Beijing, Beijing, China|
|Siam Cement Group||Bangkok, Krung Thep, Thailand|
|Solis Capital Partners||California, Newport Beach, United States|
|TCR Capital||France, Ile-de-France, Paris|
|Times Bridge||California, Redwood City, United States|
|Walker & Dunlop||Bethesda, Maryland, United States|
|Willfly Ventures||India, Maharashtra, Mumbai|
|$7M||21 May 2019||Old Toronto, Ontario, Canada|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.